PharmiWeb35m
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized ...
PharmiWeb3h
US Med-Equip Named 'Top Workplace' for 6th Year Running, Fueled by Employee Dedication to Life-Saving Mission
Leading medical equipment provider recognized for its 'people-first culture,'empowering working environment supporting hospitalsHOUSTON, TX / ACCESSWIRE / November 11, 2024 / Employees at US Med-Equip ...
PharmiWeb4h
Formycon extends Management Board contract for CEO…
Personnel/ContractFormycon extends Management Board contract for CEO Dr. Stefan Glombitza until 2027 and receives admission to trading in the Prime Standard 11.11.2024 / 17:41 CET/CESTThe issuer is ...
PharmiWeb4h
The Tandem Meetings of ASTCT and CIBMTR Return to Hawai'i From February 12-15, 2025
ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy. Throughout the meetings, world-class ...
PharmiWeb6h
The Rise of Elastography Imaging: A Multi-Billion Dollar Industry
The global elastography imaging market is experiencing significant growth, with projections indicating that the industry will ...
PharmiWeb6h
Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers
Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers - First SMC acceptance of any CAR T-cell therapy for lymphoma patients in the ...
PharmiWeb6h
InnoScot Health innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS Scotland
New innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS ScotlandFormal NHS Scotland partner InnoScot Health is launching a fresh innovation push with the aim of inspiring ...
PharmiWeb7h
William H Morris, MD MBA, Joins Ambience Healthcare as Chief Medical Officer
SAN FRANCISCO, CA / ACCESSWIRE / November 11, 2024 / Ambience Healthcare - the leading clinical AI platform for scribing, point-of-care CDI & coding, patient summaries, and referrals - today announced ...
PharmiWeb8h
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...
PharmiWeb8h
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...
PharmiWeb12h
STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announces that it presented promising data from its ...
PharmiWeb12h
SMC recommends Yselty® (linzagolix) for treating…
Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...